BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33904315)

  • 1. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
    Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
    Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors.
    Shcherbina V; Gordiienko I; Shlapatska L; Ivanivska T; Sidorenko S
    Exp Oncol; 2020 Mar; 42(1):16-24. PubMed ID: 32231196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
    Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
    Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
    PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.
    Gordiienko I; Shcherbina V; Shlapatska L
    Exp Oncol; 2024 Feb; 45(4):457-462. PubMed ID: 38328844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line.
    Tsertsvadze T; Mitskevich N; Ghirdaladze D; Porakishvili N
    Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
    Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
    Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
    Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
    Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
    Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
    Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
    Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
    Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
    Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
    di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
    Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
    Gautam A; Sreedharanunni S; Sachdeva MUS; Rana S; Kashyap D; Bose P; Bal A; Prakash G; Malhotra P; Das R; Varma N
    Int J Lab Hematol; 2021 Oct; 43(5):1123-1131. PubMed ID: 33455071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-25 Impact on Malignant B Cells Survival and T Cells Activation in Chronic Lymphocytic Leukemia.
    Pashei M; Ghahremanfard F; Manouchehri Doulabi E; Hemmati M; Pak F; Kokhaei P
    Iran J Allergy Asthma Immunol; 2023 Jun; 22(3):299-311. PubMed ID: 37524666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD150-mediated Akt signalling pathway in normal and malignant B cells.
    Yurchenko M; Shlapatska LM; Romanets OL; Ganshevskiy D; Kashuba E; Zamoshnikova A; Ushenin YV; Snopok BA; Sidorenko SP
    Exp Oncol; 2011 Mar; 33(1):9-18. PubMed ID: 21423089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
    Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
    Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.